Clinical Trial Update: Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab

View source ↗

Summary

This trial update summarizes results for patients with low-grade non-Hodgkin lymphoma who were previously treated with Tositumomab and/or iodine-131 Tositumomab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Non-hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Iodine-131 (Iodine-131)
• Tositumomab (tositumomab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lymphoma, Non-Hodgkin | Status: COMPLETED